Sunshine Lake Pharma Co Ltd

NEW
HKSE:06887 (China)   Ordinary Shares - Class H
HK$ 37.5 +0.12 (+0.32%) Aug 20
71.78
P/B:
4.51
Market Cap:
HK$ 29.39B ($ 3.74B)
Enterprise V:
HK$ 32.94B ($ 4.20B)
Volume:
20.80K
Avg Vol (2M):
800.21K
Trade In:
Volume:
20.80K
Avg Vol (2M):
800.21K

Business Description

Description
Sunshine Lake Pharma Co Ltd is a vertically integrated pharmaceutical company principally engaged in the research and development, manufacturing and sales of pharmaceuticals. It is focused on therapeutic areas of infectious diseases, chronic diseases and oncology. The company's revenue is mainly derived from sales of pharmaceutical products to distributors in the PRC.
Name Current Vs Industry Vs History
Cash-To-Debt
0.32
Equity-to-Asset
0.36
Debt-to-Equity
1.08
Debt-to-EBITDA
7.01
Interest Coverage
2.75
Piotroski F-Score
7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
2.42
Distress
Grey
Safe
Beneish M-Score
-2.83
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Revenue Growth Rate
4.7
3-Year FCF Growth Rate
13.1

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
57.39
9-Day RSI
54.73
14-Day RSI
53.25
3-1 Month Momentum %
-13.01
6-1 Month Momentum %
-23.52
12-1 Month Momentum %
-37.41

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
0.77
Quick Ratio
0.64
Cash Ratio
0.25
Days Inventory
243.23
Days Sales Outstanding
112.87
Days Payable
396.48

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield %
-0.88

Financials

HKSE:06887's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Sunshine Lake Pharma Co Ltd Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil HK$) 5,296.718
EPS (TTM) (HK$) 0.523
Beta -
3-Year Sharpe Ratio -
3-Year Sortino Ratio -
Volatility % -
14-Day RSI 53.25
14-Day ATR (HK$) 2.2552
20-Day SMA (HK$) 36.88
12-1 Month Momentum % -37.41
52-Week Range (HK$) 15.01 - 56
Shares Outstanding (Mil) 574.53

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sunshine Lake Pharma Co Ltd Filings

Filing Date Document Date Form
No Filing Data

Sunshine Lake Pharma Co Ltd Stock Events

Financials Calendars
Event Date Price (HK$)
No Event Data

Sunshine Lake Pharma Co Ltd Frequently Asked Questions

What is Sunshine Lake Pharma Co Ltd(HKSE:06887)'s stock price today?
The current price of HKSE:06887 is HK$37.50. The 52 week high of HKSE:06887 is HK$56.00 and 52 week low is HK$15.01.
When is next earnings date of Sunshine Lake Pharma Co Ltd(HKSE:06887)?
The next earnings date of Sunshine Lake Pharma Co Ltd(HKSE:06887) is .
Does Sunshine Lake Pharma Co Ltd(HKSE:06887) pay dividends? If so, how much?
Sunshine Lake Pharma Co Ltd(HKSE:06887) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on Sunshine Lake Pharma Co Ltd

No articles.